vs
UiPath, Inc.（PATH）とSotera Health Co（SHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
UiPath, Inc.の直近四半期売上が大きい（$411.1M vs $303.4M、Sotera Health Coの約1.4倍）。UiPath, Inc.の純利益率が高く（48.4% vs 11.5%、差は36.9%）。UiPath, Inc.の前年同期比売上増加率が高い（15.9% vs 4.6%）。Sotera Health Coの直近四半期フリーキャッシュフローが多い（$52.4M vs $25.1M）。過去8四半期でSotera Health Coの売上複合成長率が高い（10.6% vs 0.7%）
UiPath Inc.は人工知能（AI）、自律型オートメーションおよびオーケストレーションソフトウェアを開発するグローバルソフトウェア企業です。同社の製品は複雑な業務プロセスやワークフローを自動化するAIエージェントの構築・管理に対応し、各業界の業務効率向上を支援しています。
Sotera Health Coは医療安全ソリューションをグローバルに提供する企業で、医療機器メーカー、製薬会社、食品・消費財企業を対象に滅菌サービス、分析検査、規制対応コンサルティングを提供し、顧客の製品安全性確保と基準準拠を支援しています。
PATH vs SHC — 直接比較
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $411.1M | $303.4M |
| 純利益 | $198.8M | $34.8M |
| 粗利率 | 83.3% | 54.7% |
| 営業利益率 | 3.2% | 23.2% |
| 純利益率 | 48.4% | 11.5% |
| 売上前年比 | 15.9% | 4.6% |
| 純利益前年比 | 1966.2% | 182.8% |
| EPS（希薄化後） | $0.37 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $411.1M | $303.4M | ||
| Q3 25 | $361.7M | $311.3M | ||
| Q2 25 | $356.6M | $294.3M | ||
| Q1 25 | $423.6M | $254.5M | ||
| Q4 24 | $354.7M | $290.2M | ||
| Q3 24 | $316.3M | $285.5M | ||
| Q2 24 | $335.1M | $276.6M | ||
| Q1 24 | $405.3M | $248.2M |
| Q4 25 | $198.8M | $34.8M | ||
| Q3 25 | $1.6M | $48.4M | ||
| Q2 25 | $-22.6M | $8.0M | ||
| Q1 25 | $51.8M | $-13.3M | ||
| Q4 24 | $-10.7M | $12.3M | ||
| Q3 24 | $-86.1M | $17.0M | ||
| Q2 24 | $-28.7M | $8.8M | ||
| Q1 24 | $33.9M | $6.3M |
| Q4 25 | 83.3% | 54.7% | ||
| Q3 25 | 82.2% | 57.0% | ||
| Q2 25 | 82.1% | 56.6% | ||
| Q1 25 | 84.8% | 53.2% | ||
| Q4 24 | 82.0% | 56.6% | ||
| Q3 24 | 80.0% | 55.4% | ||
| Q2 24 | 83.5% | 55.2% | ||
| Q1 24 | 86.8% | 51.2% |
| Q4 25 | 3.2% | 23.2% | ||
| Q3 25 | -5.6% | 23.4% | ||
| Q2 25 | -4.6% | 6.4% | ||
| Q1 25 | 7.9% | -5.8% | ||
| Q4 24 | -12.2% | 30.0% | ||
| Q3 24 | -32.7% | 28.2% | ||
| Q2 24 | -14.8% | 27.8% | ||
| Q1 24 | 3.7% | 21.4% |
| Q4 25 | 48.4% | 11.5% | ||
| Q3 25 | 0.4% | 15.5% | ||
| Q2 25 | -6.3% | 2.7% | ||
| Q1 25 | 12.2% | -5.2% | ||
| Q4 24 | -3.0% | 4.2% | ||
| Q3 24 | -27.2% | 6.0% | ||
| Q2 24 | -8.6% | 3.2% | ||
| Q1 24 | 8.4% | 2.5% |
| Q4 25 | $0.37 | $0.12 | ||
| Q3 25 | $0.00 | $0.17 | ||
| Q2 25 | $-0.04 | $0.03 | ||
| Q1 25 | $0.09 | $-0.05 | ||
| Q4 24 | $-0.02 | $0.05 | ||
| Q3 24 | $-0.15 | $0.06 | ||
| Q2 24 | $-0.05 | $0.03 | ||
| Q1 24 | $0.07 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $1.4B | $344.6M |
| 総負債低いほど良い | — | $2.1B |
| 株主資本純資産 | $1.9B | $606.0M |
| 総資産 | $2.9B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | — | 3.53× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $1.4B | $344.6M | ||
| Q3 25 | $1.4B | $299.2M | ||
| Q2 25 | $1.6B | $332.4M | ||
| Q1 25 | $1.6B | $304.4M | ||
| Q4 24 | $1.6B | $277.2M | ||
| Q3 24 | $1.7B | $306.7M | ||
| Q2 24 | $1.9B | $246.1M | ||
| Q1 24 | $1.9B | $261.1M |
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $1.9B | $606.0M | ||
| Q3 25 | $1.7B | $550.5M | ||
| Q2 25 | $1.7B | $511.3M | ||
| Q1 25 | $1.8B | $414.1M | ||
| Q4 24 | $1.7B | $404.9M | ||
| Q3 24 | $1.8B | $470.2M | ||
| Q2 24 | $2.0B | $422.8M | ||
| Q1 24 | $2.0B | $429.4M |
| Q4 25 | $2.9B | $3.3B | ||
| Q3 25 | $2.6B | $3.2B | ||
| Q2 25 | $2.6B | $3.2B | ||
| Q1 25 | $2.9B | $3.1B | ||
| Q4 24 | $2.7B | $3.1B | ||
| Q3 24 | $2.7B | $3.1B | ||
| Q2 24 | $2.8B | $3.1B | ||
| Q1 24 | $3.0B | $3.1B |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.89× | ||
| Q2 25 | — | 4.34× | ||
| Q1 25 | — | 5.36× | ||
| Q4 24 | — | 5.49× | ||
| Q3 24 | — | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | — | 5.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.3M | $103.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $25.1M | $52.4M |
| FCFマージンFCF / 売上 | 6.1% | 17.3% |
| 設備投資強度設備投資 / 売上 | 0.8% | 16.7% |
| キャッシュ転換率営業CF / 純利益 | 0.14× | 2.96× |
| 直近12ヶ月FCF直近4四半期 | — | $149.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $28.3M | $103.1M | ||
| Q3 25 | $41.6M | $71.2M | ||
| Q2 25 | $119.0M | $57.4M | ||
| Q1 25 | $146.1M | $55.5M | ||
| Q4 24 | $28.1M | $55.7M | ||
| Q3 24 | $46.4M | $97.5M | ||
| Q2 24 | $100.0M | $61.3M | ||
| Q1 24 | $145.6M | $9.7M |
| Q4 25 | $25.1M | $52.4M | ||
| Q3 25 | — | $35.0M | ||
| Q2 25 | $106.2M | $26.2M | ||
| Q1 25 | $138.7M | $35.6M | ||
| Q4 24 | $23.2M | $-10.2M | ||
| Q3 24 | $45.0M | $61.1M | ||
| Q2 24 | $98.8M | $19.4M | ||
| Q1 24 | $141.8M | $-25.2M |
| Q4 25 | 6.1% | 17.3% | ||
| Q3 25 | — | 11.2% | ||
| Q2 25 | 29.8% | 8.9% | ||
| Q1 25 | 32.7% | 14.0% | ||
| Q4 24 | 6.5% | -3.5% | ||
| Q3 24 | 14.2% | 21.4% | ||
| Q2 24 | 29.5% | 7.0% | ||
| Q1 24 | 35.0% | -10.2% |
| Q4 25 | 0.8% | 16.7% | ||
| Q3 25 | 0.0% | 11.6% | ||
| Q2 25 | 3.6% | 10.6% | ||
| Q1 25 | 1.7% | 7.8% | ||
| Q4 24 | 1.4% | 22.7% | ||
| Q3 24 | 0.4% | 12.7% | ||
| Q2 24 | 0.4% | 15.2% | ||
| Q1 24 | 0.9% | 14.1% |
| Q4 25 | 0.14× | 2.96× | ||
| Q3 25 | 26.25× | 1.47× | ||
| Q2 25 | — | 7.21× | ||
| Q1 25 | 2.82× | — | ||
| Q4 24 | — | 4.52× | ||
| Q3 24 | — | 5.73× | ||
| Q2 24 | — | 7.00× | ||
| Q1 24 | 4.29× | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
